Skip to main content
. 2022 Jul 21;27(11):e878–e888. doi: 10.1093/oncolo/oyac131

Table 1.

Patient characteristics (n = 291).

Variable n (%)
Age (years) 72 (IQR 68-77)
 65-69 97 (33.3)
 70-74 82 (28.2)
 75-79 72 (24.7)
 80-84 31 (10.7)
 ≥85 9 (3.1)
Male 164 (56.4)
WHO performance score
 0 81 (28.3)
 1 178 (62.2)
 2 22 (7.7)
 3 5 (1.7)
 Unknown 5 (1.7)
Social status
 With partner and fully independent 151 (53.0)
 Without partner and fully independent 42 (14.4)
 With partner and housekeeping aid 47 (16.2)
 Without partner, with housekeeping aid 17 (5.8)
 With partner and medical care at home 16 (5.5)
 Without partner, with medical care at home 6 (2.1)
 Necessarily living with other family 5 (1.7)
 Institutional health care 1 (0.3)
 Missing 6
Tumor type and treatment setting
  (Neo)adjuvant chemotherapy for solid malignancy 72 (24.7)
 Palliative chemotherapy for solid malignancy 49 (16.8)
 Indolent hematological malignancy 115 (39.5)
 Aggressive hematological malignancy 55 (18.9)